Delhi institute’s project attempting to use AI to speed up search for pneumonia therapeutics

NEW DELHI: (Mar 31) A new India-Sweden research collaboration at Indraprastha Institute of Information Technology, Delhi is betting on artificial intelligence helping scientists outpace deadly pneumonia germs.

They are doing this by using AI to design peptide-based therapeutics that could one day shorten drug discovery timelines and open new pathways against hard-to-treat infections.

Titled “AI-based bio-design for developing peptide therapeutics against pneumonia-causing pathogens with experimental validation”, the project brings together researchers from India and Sweden to use artificial intelligence and computational biology in the search for new treatments for respiratory infections.